Dr. Rachel Rabinovitch is a Professor of Radiation Oncology at the University of Colorado Hospital. She completed her residency in radiation oncology at Memorial Sloan-Kettering Cancer Center in New York, where she also served as Chief Resident, and earned her M.D. from Albert Einstein College of Medicine. She is an active member of the University of Colorado Hospital’s Breast Center, Multi-disciplinary Breast Cancer Clinic, and Hematopoietic Malignancy and Stem Cell Transplantation Team.
Dr. Rabinovitch has expertise in the treatment of breast cancer, accelerated partial breast irradiation, lymphoma, total body irradiation and Hodgkin’s disease. She has been repeatedly selected as a “Top Doctor” in Radiation Oncology by her peers in the annual 5280 Magazine poll.
As primary investigator for all Radiation Therapy Oncology Group (RTOG) studies at the institution, Dr. Rabinovitch is involved with clinical research across numerous disease sites. She is a co-PI of the largest breast radiation research trial ever conducted in North America comparing whole breast to partial breast irradiation (RTOG 0413), a trial sponsored by the National Institute of Health (NIH).
She is active in national breast cancer research and serves in leadership positions on numerous national research committees which include:
Chair, Radiation Therapy Oncology Group (RTOG) Quality Control Committee, 2007-present
NCI Breast Cancer Steering Committee, Breast Oncology Local Disease (BOLD) Task Force, Member, 2009-present
American Society of Therapeutic Radiology and Oncology’s (ASTRO) Breast Resource Panel of the Clinical Affairs and Quality Committee, Member, 2011-2012
Radiation Therapy Oncology Group (RTOG), Breast Working Group, steering committee member, August 1997-present
She has published dozens of original articles, reviews and book chapters, and she presents her research regularly at national and international scientific meetings.